Modified Herpes Virus Shows Promise in Treating Advanced Melanoma
A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes virus can be genetically modified to combat advanced melanoma, offering a glimmer of hope for patients with this aggressive form...
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma
A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes virus can be genetically modified to combat advanced melanoma, offering a glimmer of hope for patients with this aggressive form...
Modified Herpes Virus Shows Promise in Treating Advanced Melanoma
A study conducted by researchers from the University of Southern California’s Keck Medicine of USC has revealed that the herpes virus can be genetically modified to combat advanced melanoma, offering a glimmer of hope for patients with this aggressive form...
Sekur Private Data Ltd. Adjusts Pricing Strategy in Response to Increased Cybersecurity Demand
Sekur Private Data Ltd. (CSE: SKUR) (OTCQX: SWISF) (FSE: GDT0), a provider of Swiss-hosted cybersecurity and communication solutions, has announced an increase in pricing across all its service tiers. This decision comes as a direct response to the escalating demand...
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials
Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement with Sterling Pharma Solutions. This partnership is for the Good Manufacturing Practice (GMP) production of ONP-002, Oragenics’ lead drug candidate...
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials
Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement with Sterling Pharma Solutions. This partnership is for the Good Manufacturing Practice (GMP) production of ONP-002, Oragenics’ lead drug candidate...
Oragenics Inc. Secures U.S. Manufacturing Partner for Concussion Drug Ahead of Phase IIb Trials
Oragenics Inc. (NYSE American: OGEN), a biotechnology firm specializing in intranasal therapeutics for brain-related conditions, has announced a manufacturing agreement with Sterling Pharma Solutions. This partnership is for the Good Manufacturing Practice (GMP) production of ONP-002, Oragenics’ lead drug candidate...
TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista
TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and Statista, marking a significant milestone for the Central Asian region. This recognition underscores the company’s exceptional performance in key financial...
TBC Uzbekistan Named Among Global Fintech Leaders by CNBC and Statista
TBC Uzbekistan has been acknowledged as one of the world’s leading fintech companies in the neobanking category by CNBC and Statista, marking a significant milestone for the Central Asian region. This recognition underscores the company’s exceptional performance in key financial...
Brian Fricker of Staffing Partners Inc. Highlights Innovative Staffing Solutions on Innovators’ Journey
Brian Fricker, the president of Staffing Partners Inc. and a notable figure listed in Marquis Who’s Who, recently appeared on Innovators’ Journey to discuss the distinctive approach his company takes in the staffing industry. Staffing Partners Inc., under Fricker’s guidance,...
